Trials / Completed
CompletedNCT01025700
Nabilone & Marijuana Addiction
A Double-Blind Placebo Control Study on the Use of Nabilone for Outpatient Management of Acute Marijuana Withdrawal
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Safety of Nabilone in reducing marijuana craving
Detailed description
Randomized double blind trial into the safety and efficacy of Cesemat for the treatment of marijuana use
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cesemat | 1 mg capsule per day for 21 days |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-06-01
- Completion
- 2010-10-01
- First posted
- 2009-12-03
- Last updated
- 2011-02-17
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01025700. Inclusion in this directory is not an endorsement.